Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04872777 · ClinicalTrials.gov registry record · NA
Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH
A NA study of Non-alcoholic Steatohepatitis, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04872777 is a NA study of Non-alcoholic Steatohepatitis that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 40 participants, below the 293-participant average among 12 other Non-alcoholic Steatohepatitis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04872777, a NA study of Non-alcoholic Steatohepatitis, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
There is a clear unmet clinical need for effective lifestyle intervention in patients with nonalcoholic steatohepatitis (NASH). Patients have self-identified multiple barriers to effective lifestyle intervention can be removed with a mobile health (mHealth) platform. This study will be a proof of concept study to evaluate weight loss efficacy of Noom Healthy Weight (HW), a mHealth lifestyle intervention, in patients with NASH.
Conditions Studied
Interventions
- BEHAVIORAL Noom Healthy Weight
Study Locations (1)
Pennsylvania
- Penn State Hershey Medical Center - Marietta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-06-08 |
| Est. Completion | 2022-02-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04872777
The ClinicalTrials.gov registry entry for NCT04872777 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 12 other Non-alcoholic Steatohepatitis trials with a reported enrollment target (86% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-alcoholic Steatohepatitis appearing as the primary indexed condition, and to 1 intervention - of which Noom Healthy Weight is the first listed.
NCT04872777 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04872777 about?
NCT04872777 is a clinical study titled "Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH". There is a clear unmet clinical need for effective lifestyle intervention in patients with nonalcoholic steatohepatitis (NASH). Patients have self-identified multiple barriers to effective lifestyle intervention can be removed with a mobile health (mHealth) platform. This study will be a proof of c...
What is the current status of trial NCT04872777?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-06-08. Estimated completion is 2022-02-10.
What conditions does trial NCT04872777 study?
This clinical trial studies the following conditions: Non-alcoholic Steatohepatitis.
What interventions are being tested in trial NCT04872777?
The interventions under investigation include: Noom Healthy Weight (BEHAVIORAL).
Who is sponsoring clinical trial NCT04872777?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04872777 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-alcoholic Steatohepatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Olmsted NAFLD Epidemiology Study (TONES)
RECRUITING · NA
-
Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease
RECRUITING
-
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
RECRUITING · Phase 2
-
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
ACTIVE NOT RECRUITING · Phase 3
-
Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis
COMPLETED · Phase 2
-
An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.